Physician

Adam Sweeney, M.D.

According to 2025 Medicare claims, Adam Sweeney, M.D. (NPI: 1023436896) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is TIMOTHY F. MCDEVITT, M.D. INC (NPI: 1639339013; TIN: 990337751) and primary practice location at 96813-2443. Sweeney is affiliated with the QCIPN (ACO ID: A4614) and CHI Saint Joseph Health Partners (ACO ID: A4638), participating under the MSSP model.

Sweeney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 633 traditional Medicare patients, billed 5,492 HCPCS/CPT codes, and received $498,333 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 885 prescription claims across 555 beneficiaries totaling $2,187,544 in drug costs, led by Tepezza (Teprotumumab-Trbw). Open Payments data shows 64 records totaling $36,961. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $35,435 to $498,333. Similarly, Part D prescription costs have risen steadily, from $3,433 to $2,187,544. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$249K$498K2020 Medicare payment: $35,435 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $201,095 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $295,647 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $449,928 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $498,333 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202054295$35,435
20212351,728$201,095
20223322,681$295,647
20235284,255$449,928
20246335,492$498,333

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $3,433 (USD; Tot_Drug_Cst)2016 Drug cost: $5,888 (USD; Tot_Drug_Cst)2017 Drug cost: $14,989 (USD; Tot_Drug_Cst)2018 Drug cost: $19,366 (USD; Tot_Drug_Cst)2019 Drug cost: $2,906 (USD; Tot_Drug_Cst)2020 Drug cost: $83,112 (USD; Tot_Drug_Cst)2021 Drug cost: $301,802 (USD; Tot_Drug_Cst)2022 Drug cost: $514,673 (USD; Tot_Drug_Cst)2023 Drug cost: $188,611 (USD; Tot_Drug_Cst)2024 Drug cost: $2,187,544 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152451$3,433
20164281$5,888
201792248$14,989
201859349$19,366
20191631$2,906
20202642$83,112
2021224440$301,802
2022342628$514,673
2023527872$188,611
2024555885$2,187,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more317317$122
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more420705$92
83861Microfluid analysis of tears424960$22
92285Photography of content of eyes488673$18
J2250Injection, midazolam hydrochloride, per 1 mg168344$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TepezzaTeprotumumab-Trbw40840$2,158,229
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha5838,131$10,364
RestasisCyclosporine12360$7,502
Fluticasone PropionateFluticasone Propionate924,334$1,006
ErythromycinErythromycin Base43671$505

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.64$36,961Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Sweeney, M.D.?

Tedicare shows public-source Medicare data for Adam Sweeney, M.D. (NPI 1023436896), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Sweeney, M.D. have ACO affiliation data?

Adam Sweeney, M.D. is shown with ACO affiliation data for QCIPN (MSSP, ACO ID A4614) and CHI Saint Joseph Health Partners (MSSP, ACO ID A4638).

What billing organization is linked to Adam Sweeney, M.D.?

Adam Sweeney, M.D. is linked to TIMOTHY F. MCDEVITT, M.D. INC (billing NPI 1639339013) in the available physician profile data.

Does Adam Sweeney, M.D. have Open Payments data?

Adam Sweeney, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.